Disease-modifying trials in Alzheimer's disease: a European task force consensus
Author:
Publisher
Elsevier BV
Subject
Neurology (clinical)
Reference36 articles.
1. Treatment of Alzheimer's disease: current status and new perspectives;Scarpini;Lancet Neurol,2003
2. Secretase inhibitors for Alzheimer's disease: challenges of a promiscuous protease;Pollack;Curr Opin Investig Drugs,2005
3. Immunotherapy for Alzheimer's disease;Dodel;Lancet Neurol,2003
4. The development of anti-amyloid therapy for Alzheimer's disease: from secretase modulators to polymerisation inhibitors;Aisen;CNS Drugs,2005
5. Vitamin E and donepezil for the treatment of mild cognitive impairment;Petersen;N Engl J Med,2005
Cited by 126 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Donanemab in Early Symptomatic Alzheimer Disease;JAMA;2023-08-08
2. Disease modification in inflammatory skin disorders: opportunities and challenges;Nature Reviews Drug Discovery;2023-07-13
3. Meaningful Clinical Changes in Alzheimer Disease Measured With the iADRS and Illustrated Using the Donanemab TRAILBLAZER-ALZ Study Findings;Neurology Clinical Practice;2023-04
4. Lecanemab en la enfermedad de Alzheimer: ¿realmente estamos ante un cambio en el pronóstico de la enfermedad?;Revista de Neurología;2023
5. Assessing the Cost-effectiveness of a Hypothetical Disease-modifying Therapy With Limited Duration for the Treatment of Early Symptomatic Alzheimer Disease;Clinical Therapeutics;2022-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3